Skip to content
About
Management
Board of Directors
Scientific Advisory Board
Therapeutic Areas
Pipeline
OLX07010 in Rare Tauopathies
OLX07010 Alzheimer’s
Technology
MOA
Patents
News & Publications
Partners and Collaborators
Contact Us
Menu
Oligomerix Relocates Headquarters to Accommodate Growth
Home
>
News
>
Oligomerix Relocates Headquarters to Accommodate Growth
Print
Oligomerix
>
News
>
Oligomerix Relocates Headquarters to Accommodate Growth
Oligomerix Relocates Headquarters to Accommodate Growth
Post navigation
Previous Post
Oligomerix Awarded a $3.19 Million Grant from NIA BioWorld
Next Post
Oligomerix Relocation of Headquarters BioWorld
vera
View posts by vera
Scroll to top
close ×
